These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24119112)

  • 1. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
    Matsuoka H; Kuwajima I; Shimada K; Mitamura H; Saruta T
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):806-14. PubMed ID: 24119112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
    Momomura SI; Saito Y; Yasumura Y; Yamamoto K; Sakata Y; Daimon M; Kinugawa K; Okamoto H; Dohi N; Komuro I
    Circ J; 2017 Dec; 82(1):141-147. PubMed ID: 28768917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
    Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
    J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
    Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
    Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM; Cargo P; Graepel J; Humphrey D; King E; Rolf C; Cunningham RJ
    Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
    Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.
    Suojanen L; Haring A; Tikkakoski A; Koskela JK; Tahvanainen AM; Huhtala H; Kähönen M; Sipilä K; Eräranta A; Mustonen JT; Kivistö K; Pörsti IH
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):130-137. PubMed ID: 28256104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
    Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity.
    Brion R; Carré F; Verdier JC; Poncelet P; Douard H; Page E; Amoretti R; Gauthier J; Ducardonnet A; Gressin V; Dubanchet A
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):78-83. PubMed ID: 10630736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
    Williams B; MacDonald TM; Morant S; Webb DJ; Sever P; McInnes G; Ford I; Cruickshank JK; Caulfield MJ; Salsbury J; Mackenzie I; Padmanabhan S; Brown MJ;
    Lancet; 2015 Nov; 386(10008):2059-2068. PubMed ID: 26414968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
    Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
    Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisoprolol in the treatment of hypertension in the elderly.
    Broncel M; Chojnowska-Jezierska J; Adamska-Dyniewska H
    J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group.
    Neutel JM; Smith DH; Ram CV; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Cardiol; 1993 Jul; 72(1):41-6. PubMed ID: 8517426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.